Tetsuya Higuchi Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

7/2021	Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies.
5/2004	Ectopic CD40 ligand expression on B cells triggers intestinal inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuya Higuchi Research Topics

Disease

56	Neoplasms (Cancer) 01/2022 - 05/2002
9	Pheochromocytoma 03/2022 - 06/2008
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 10/2004
7	Squamous Cell Carcinoma of Head and Neck 08/2021 - 06/2005
6	Paraganglioma (Paragangliomas) 03/2022 - 06/2008
6	Hypoxia (Hypoxemia) 02/2020 - 12/2006
6	Lung Neoplasms (Lung Cancer) 01/2020 - 09/2003
4	Neoplasm Metastasis (Metastasis) 01/2016 - 06/2008
3	Lymphoma (Lymphomas) 08/2022 - 08/2006
3	Neuroblastoma 01/2021 - 02/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2014
3	Thyroid Neoplasms (Thyroid Cancer) 04/2020 - 12/2014
3	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 02/2014
3	Glioma (Gliomas) 12/2017 - 07/2003
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2015 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021 - 05/2004
2	Hemorrhage 01/2021 - 01/2015
2	Siderosis 01/2021 - 01/2015
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2019
2	Allergic Contact Dermatitis 01/2021 - 09/2017
2	Adenoma (Adenomas) 07/2017 - 06/2015
2	Inflammation (Inflammations) 07/2015 - 05/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2009 - 07/2005
2	Cholangiocarcinoma 02/2008 - 01/2008
2	Hepatocellular Carcinoma (Hepatoma) 01/2008 - 12/2007
2	Autoimmune Diseases (Autoimmune Disease) 05/2004 - 01/2002
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023
1	Multiple System Atrophy 01/2023
1	Prurigo 01/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Parkinsonian Disorders (Parkinsonism) 01/2023
1	Dementia (Dementias) 01/2023
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Cicatrix (Scar) 09/2022
1	Glioblastoma (Glioblastoma Multiforme) 08/2022
1	Pseudolymphoma 01/2022
1	Ulcer 07/2021
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2021

Drug/Important Bio-Agent (IBA)

23	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 07/2003
12	Amino Acids FDA Link 01/2020 - 06/2013
11	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2004
10	Deoxyglucose (2 Deoxy D glucose)IBA 01/2016 - 02/2004
7	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021 - 01/2008
7	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 10/2010
6	3-Iodobenzylguanidine (Iobenguane)IBA 03/2022 - 06/2008
6	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019 - 03/2009
5	IodineIBA 04/2020 - 07/2011
5	Monoclonal AntibodiesIBA 10/2016 - 07/2003
4	HexokinaseIBA 01/2021 - 06/2005
4	CD40 Ligand (CD40L)IBA 01/2014 - 01/2002
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
3	Therapeutic UsesIBA 01/2018 - 01/2014
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023 - 01/2020
2	Cetuximab (Erbitux)FDA Link 08/2021 - 10/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	technetium tc-99m tetrofosmin (Myoview)FDA Link 01/2021 - 01/2019
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 09/2017
2	Immune Checkpoint InhibitorsIBA 06/2020 - 10/2016
2	Cadherins (E-Cadherin)IBA 01/2020 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 10/2019 - 07/2003
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2019 - 07/2009
2	AntigensIBA 02/2019 - 01/2014
2	Fluorine-18IBA 11/2018 - 12/2017
2	NivolumabIBA 01/2018 - 10/2016
2	FluorineIBA 01/2018 - 01/2018
2	Radioisotopes (Radionuclides)IBA 01/2018 - 01/2016
2	alpha-Methyltyrosine (Metirosine)FDA Link 12/2014 - 02/2007
2	Indium-111IBA 03/2014 - 07/2009
2	Yttrium-90IBA 08/2012 - 07/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 03/2009
2	Choline (Choline Chloride)IBA 07/2004 - 02/2004
1	Adalimumab (Humira)FDA Link 01/2023
1	dupilumabIBA 01/2023
1	ioflupaneIBA 01/2023
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 09/2022
1	Succimer (Dimercaptosuccinic Acid)FDA Link 09/2022
1	IsotopesIBA 08/2022
1	Probenecid (Benemid)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Organic Anion TransportersIBA 01/2022
1	VX (EDIM)IBA 08/2021
1	SteroidsIBA 07/2021
1	benzylguanidineIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021

Therapy/Procedure

16	Therapeutics 03/2022 - 06/2004
5	Drug Therapy (Chemotherapy) 12/2016 - 10/2004
5	Radiotherapy 07/2015 - 04/2006
4	Radioimmunotherapy 08/2012 - 07/2005
2	Renal Dialysis (Hemodialysis) 01/2019 - 02/2016
2	Chemoradiotherapy 12/2014 - 02/2014
2	Injections 08/2012 - 06/2006
2	Aftercare (After-Treatment) 02/2010 - 07/2009
2	Gamma Cameras (Gamma Camera) 09/2003 - 07/2003
1	Ostomy 07/2021